Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

REVISION OPTICS, INC.

US

Last updated May 30, 2026

What REVISION OPTICS, INC. makes

Revision Optics, Inc. manufactures corneal inlays designed to reduce aperture size for near vision correction, including the Raindrop Near Vision Inlay. They also produce manual ophthalmic surgical instrument handles, such as the Inlay Inserter Chuck Handle, used in procedures involving corneal implants.

The company’s products are classified as Class III devices under FDA regulations and are listed in the FDA’s Unique Device Identifier (UDI) database. Revision Optics, Inc. is headquartered in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Revision Optics, Inc. manufacture?

Revision Optics, Inc. specializes in two primary categories of ophthalmic devices: corneal inlays that reduce the aperture size for near vision correction, such as the Raindrop Near Vision Inlay, and manual ophthalmic surgical instrument handles, like the Inlay Inserter Chuck Handle. These devices are designed to assist in vision correction procedures and surgical precision.

Where is Revision Optics, Inc. based, and how does that affect its regulatory oversight?

Revision Optics, Inc. is headquartered in the United States. Since it operates within the U.S., its devices are subject to FDA regulations, including classification under the FDA’s device classification system. This means compliance with U.S. regulatory requirements is a key consideration for the company’s products.

Which regulatory registries or databases list devices manufactured by Revision Optics, Inc.?

Devices produced by Revision Optics, Inc. are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices under FDA oversight, ensuring traceability and compliance with regulatory requirements.

How are devices from Revision Optics, Inc. classified under FDA regulations?

All devices manufactured by Revision Optics, Inc. fall under Class III classification according to FDA regulations. This classification applies to devices that support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential unreasonable risk of illness or injury. Class III devices require premarket approval (PMA) or are exempt from PMA but still subject to strict regulatory controls.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
LinkedIn
—
Facebook
—
Phone
949-707-2740
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
015504442

Catalogue (2)

DeviceModel / ReferenceRegistriesClassStatus
Raindrop Near Vision Inlay RD1-1
FDA UDI
Class IIIActive
Inlay Inserter Chuck Handle 607-0002
FDA UDI
Class IIIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (1)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Revision Optics, Inc. has one FDA recall record initiated on February 7, 2017, which is marked as terminated. The recall pertains to an update to the instructions for use for the Raindrop Near Vision Inlay, clarifying that only Balanced Salt Solution (BSS) may be used for irrigation under the flap and specifying that topical medications or lubricants should not be administered until the inlay is properly centered and the flap is healed.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Feb 7, 2017Z-1518-2017—terminated

ReVision Optics has updated the instructions for use (IFU) for the Raindrop Near Vision Inlay to emphasize that only Balanced Salt Solution (BSS) may be used to irrigate under the flap and that topical medications or lubricants should not be administered until centration of the inlay and proper flap positioning has been confirmed at the slit lamp.